Financials

  • Market Capitalization 4.67 B
  • Employee 755
  • Founded 2006
  • CEO N/A
  • Website www.veracyte.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2M542
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
29.82
Relación precio/flujo de caja
4.76

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1337
DFTX
Definium Therapeutics, Inc. - Common Shares
45.85 USD-0.28%+1.93%+93.87%+203.44%5.00 B USD
1369
CRSP
CRISPR Therapeutics AG - Common Shares
50.42 USD-0.08%-13.74%-4.33%-5.65%4.86 B USD
1424
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
26.03 USD+2.12%+1.64%+22.03%+17.89%4.46 B USD
1432
LEGN
Legend Biotech Corporation - American Depositary Shares
23.81 USD-7.25%-14.51%-31.99%-25.55%4.40 B USD

Noticias